Cargando…

RHOV promotes lung adenocarcinoma cell growth and metastasis through JNK/c-Jun pathway

Lung adenocarcinoma (LUAD) is a common type of lung cancer with high frequent metastasis and a high death rate. However, genes responsible for LUAD metastasis are still largely unknown. Here, we identify an important role of ras homolog family member V (RHOV) in LUAD metastasis using a combination o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Deyu, Jiang, Qiwei, Ge, Xiangwei, Shi, Yanzhu, Ye, Tianxing, Mi, Yue, Xie, Tian, Li, Qihong, Ye, Qinong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315012/ https://www.ncbi.nlm.nih.gov/pubmed/34326698 http://dx.doi.org/10.7150/ijbs.59939

Ejemplares similares

Interaction between BEND5 and RBPJ suppresses breast cancer growth and metastasis via inhibiting Notch signaling
por: Shi, Yanzhu, et al.
Publicado: (2022)

Overexpression of RhoV Promotes the Progression and EGFR-TKI Resistance of Lung Adenocarcinoma
por: Chen, Hongjin, et al.
Publicado: (2021)

Regulation and functions of RhoU and RhoV
por: Hodge, Richard G., et al.
Publicado: (2017)

Exosomal hsa_circ_0000519 modulates the NSCLC cell growth and metastasis via miR-1258/RHOV axis
por: Wang, Rui, et al.
Publicado: (2022)

In vivo CRISPR screens identify RhoV as a pro‐metastasis factor of triple‐negative breast cancer
por: Jin, Ming‐Liang, et al.
Publicado: (2023)

Oleate acid-stimulated HMMR expression by CEBPα is associated with nonalcoholic steatohepatitis and hepatocellular carcinoma
por: Zhang, Deyu, et al.
Publicado: (2020)

CHMP4A stimulates CD8+ T‐lymphocyte infiltration and inhibits breast tumor growth via the LSD1/IFNβ axis
por: Song, Songze, et al.
Publicado: (2023)

Atypical RhoV and RhoU GTPases control development of the neural crest
por: Faure, Sandrine, et al.
Publicado: (2011)

MicroRNA-16-1-3p Represses Breast Tumor Growth and Metastasis by Inhibiting PGK1-Mediated Warburg Effect
por: Ye, Tianxing, et al.
Publicado: (2020)

Corrigendum: MicroRNA-16-1-3p Represses Breast Tumor Growth and Metastasis by Inhibiting PGK1-Mediated Warburg Effect
por: Ye, Tianxing, et al.
Publicado: (2021)

The Roles of c-Jun N-Terminal Kinase (JNK) in Infectious Diseases
por: Chen, Jing, et al.
Publicado: (2021)

A new prognostic model for RHOV, ABCC2, and CYP4B1 to predict the prognosis and association with immune infiltration of lung adenocarcinoma
por: Li, Qiao, et al.
Publicado: (2023)

CFIm25 inhibits hepatocellular carcinoma metastasis by suppressing the p38 and JNK/c-Jun signaling pathways
por: Wang, Yunwu, et al.
Publicado: (2018)

HPIP is an essential scaffolding protein running through the EGFR-RAS-ERK pathway and drives tumorigenesis
por: Jiang, Qiwei, et al.
Publicado: (2023)

C-Jun N-terminal kinase (JNK) pathway activation is essential for dental papilla cells polarization
por: Luo, Jiao, et al.
Publicado: (2021)

UTRN inhibits melanoma growth by suppressing p38 and JNK/c-Jun signaling pathways
por: Zhou, Sitong, et al.
Publicado: (2021)

Alarmins and c-Jun N-Terminal Kinase (JNK) Signaling in Neuroinflammation
por: Anfinogenova, Nina D., et al.
Publicado: (2020)

MiR-3180 inhibits hepatocellular carcinoma growth and metastasis by targeting lipid synthesis and uptake
por: Hong, Jie, et al.
Publicado: (2023)

Prognostic significance of the rho GTPase RHOV and its role in tumor immune cell infiltration: a comprehensive pan‐cancer analysis
por: Qin, Qin, et al.
Publicado: (2023)

Let-7b-5p inhibits breast cancer cell growth and metastasis via repression of hexokinase 2-mediated aerobic glycolysis
por: Li, Ling, et al.
Publicado: (2023)

ANKRD49 promotes the metastasis of NSCLC via activating JNK-ATF2/c-Jun-MMP-2/9 axis
por: Sun, Jia, et al.
Publicado: (2023)

JNK/c‐Jun pathway activation is essential for HBx‐induced IL‐35 elevation to promote persistent HBV infection
por: Li, Xuefen, et al.
Publicado: (2023)

Stressor-Like Effects of c-Jun N-Terminal Kinase (JNK) Inhibition
por: Clarke, Melanie, et al.
Publicado: (2012)

Nerve Injury-Induced c-Jun Activation in Schwann Cells Is JNK Independent
por: Lindwall Blom, Charlotta, et al.
Publicado: (2014)

MALT1 promotes melanoma progression through JNK/c-Jun signaling
por: Wang, Y, et al.
Publicado: (2017)

Activation of c-Jun by human cytomegalovirus UL42 through JNK activation
por: Koshizuka, Tetsuo, et al.
Publicado: (2020)

TLE4 promotes colorectal cancer progression through activation of JNK/c-Jun signaling pathway
por: Wang, Shu-Yang, et al.
Publicado: (2015)

GRP75‐mediated upregulation of HMGA1 stimulates stage I lung adenocarcinoma progression by activating JNK/c‐JUN signaling
por: Qiao, Guo‐Bing, et al.
Publicado: (2021)

Molecular docking of C-Jun-N-Terminal Kinase (Jnk) with amino-pyrimidine derivatives
por: Meenakumari, Krishnamoorthy, et al.
Publicado: (2020)

Role of c-Jun N-terminal Kinase (JNK) in Obesity and Type 2 Diabetes
por: Yung, Justin Hou Ming, et al.
Publicado: (2020)

ROS/JNK/C-Jun Pathway is Involved in Chaetocin Induced Colorectal Cancer Cells Apoptosis and Macrophage Phagocytosis Enhancement
por: Wang, Huihui, et al.
Publicado: (2021)

c-Jun NH(2)-Terminal Kinase (JNK)1 and JNK2 Have Distinct Roles in CD8(+) T Cell Activation
por: Conze, Dietrich, et al.
Publicado: (2002)

Basal Cancer Cell Survival Involves JNK2 Suppression of a Novel JNK1/c-Jun/Bcl-3 Apoptotic Network
por: Ahmed, Shafiq Uddin, et al.
Publicado: (2009)

Fish c-Jun N-Terminal Kinase (JNK) Pathway Is Involved in Bacterial MDP-Induced Intestinal Inflammation
por: Qu, Fufa, et al.
Publicado: (2020)

Activation of c-Jun N-Terminal Kinase (JNK) during Mitosis in Retinal Progenitor Cells
por: Ribas, Vinicius Toledo, et al.
Publicado: (2012)

C-Jun N-terminal kinase (JNK) isoforms play differing roles in otitis media
por: Yao, William, et al.
Publicado: (2014)

c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer’s Disease
por: Yarza, Ramon, et al.
Publicado: (2016)

Overexpressed DNA Polymerase Iota Regulated by JNK/c-Jun Contributes to Hypermutagenesis in Bladder Cancer
por: Yuan, Fang, et al.
Publicado: (2013)

Tenascin-C induces migration and invasion through JNK/c-Jun signalling in pancreatic cancer
por: Cai, Jun, et al.
Publicado: (2017)

Targeting c-MET by Tivantinib through synergistic activation of JNK/c-jun pathway in cholangiocarcinoma
por: Wei, Kai, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_aa9gi23qoonr7ihlkj3dob4js5